letters & comments

Letter of Support for Dr. Robert Califf FDA Commissioner Nominee

12/13/2021 Read More

NHC Comments on FDA-2020-D-2316 for Benefit-Risk Assessment for New Drug and Biological Products; Draft Guidance for Industry

11/29/2021 Read More

NHC RWE, EHR and Medical Claims Comments

11/29/2021 Read More

NHC Comments on PDUFA Reauthorization Performance Goals and Procedures FY 2023-2027

10/29/2021 Read More

CMS Physician Fee Schedule Proposed Rule

09/13/2021 Read More

Recommendations to Congress for Reconciliation Legislation

09/08/2021 Read More

Patient-Centered Outcomes Research Institute (PCORI) National Health Priorities

08/27/2021 Read More

Cures 2.0 Discussion Draft

08/26/2021 Read More

Patient Protection and Affordable Care Act; Updating Payment Parameters (NBPP)

08/05/2021 Read More
« Previous 1 2 3 4 5 6 7 8 9 10